Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical study.
BACKGROUND: Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a complete response. Photodynamic therapy (PDT) with porfimer sodium (Photofrin®) has some problems such as the requirement for shielding from light for several weeks and a high incidence of ski...
Main Authors: | Takahiro Horimatsu, Manabu Muto, Yusuke Yoda, Tomonori Yano, Yasumasa Ezoe, Shinichi Miyamoto, Tsutomu Chiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3374776?pdf=render |
Similar Items
-
Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
by: Yano Tomonori, et al.
Published: (2012-07-01) -
Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer
by: Tomonori Yano, et al.
Published: (2021-06-01) -
Skin burn related to pulse oximetry during photodynamic therapy using talaporfin sodium
by: Yuka Ino, et al.
Published: (2018-09-01) -
Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium
by: Taketo Suzuki, et al.
Published: (2020-08-01) -
Intraoperative Photodiagnosis for Malignant Glioma Using Photosensitizer Talaporfin Sodium
by: Jiro Akimoto, et al.
Published: (2019-03-01)